SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 332 filers reported holding SEATTLE GENETICS INC in Q3 2018. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $72,748,000 | +10.3% | 371,751 | -4.2% | 1.73% | +6.3% |
Q2 2020 | $65,950,000 | +42.3% | 388,123 | -3.4% | 1.63% | +15.5% |
Q1 2020 | $46,349,000 | -11.3% | 401,705 | -12.1% | 1.41% | +23.1% |
Q4 2019 | $52,238,000 | +22.4% | 457,187 | -8.6% | 1.14% | +13.7% |
Q3 2019 | $42,695,000 | +4.2% | 499,936 | -15.6% | 1.01% | +4.9% |
Q2 2019 | $40,972,000 | -11.5% | 591,999 | -6.4% | 0.96% | -8.3% |
Q1 2019 | $46,298,000 | +26.1% | 632,142 | -2.4% | 1.05% | +10.3% |
Q4 2018 | $36,711,000 | -30.2% | 647,917 | -4.9% | 0.95% | -13.1% |
Q3 2018 | $52,568,000 | +2.3% | 681,638 | -11.9% | 1.09% | +3.2% |
Q2 2018 | $51,372,000 | +9.7% | 773,784 | -13.5% | 1.06% | +15.3% |
Q1 2018 | $46,809,000 | -6.0% | 894,321 | -3.9% | 0.92% | -4.2% |
Q4 2017 | $49,791,000 | -9.0% | 930,673 | -7.5% | 0.96% | -5.2% |
Q3 2017 | $54,734,000 | +4.2% | 1,005,952 | -1.0% | 1.01% | -0.1% |
Q2 2017 | $52,553,000 | -21.4% | 1,015,717 | -4.5% | 1.01% | -20.9% |
Q1 2017 | $66,862,000 | +14.4% | 1,063,667 | -4.0% | 1.28% | +8.3% |
Q4 2016 | $58,443,000 | -7.2% | 1,107,507 | -5.1% | 1.18% | -6.7% |
Q3 2016 | $62,998,000 | +31.4% | 1,166,413 | -1.7% | 1.26% | +22.4% |
Q2 2016 | $47,935,000 | +14.1% | 1,186,218 | -1.0% | 1.03% | +14.9% |
Q1 2016 | $42,024,000 | -20.9% | 1,197,610 | +1.2% | 0.90% | -19.3% |
Q4 2015 | $53,102,000 | +10.1% | 1,183,190 | -5.4% | 1.11% | +4.4% |
Q3 2015 | $48,244,000 | -25.3% | 1,251,129 | -6.2% | 1.07% | -11.0% |
Q2 2015 | $64,572,000 | +33.1% | 1,334,136 | -2.8% | 1.20% | +32.5% |
Q1 2015 | $48,513,000 | +10.2% | 1,372,371 | +0.1% | 0.90% | +4.7% |
Q4 2014 | $44,041,000 | -9.2% | 1,370,706 | +5.1% | 0.86% | -12.6% |
Q3 2014 | $48,500,000 | -6.5% | 1,304,461 | -3.8% | 0.99% | -2.5% |
Q2 2014 | $51,891,000 | -20.0% | 1,356,616 | -4.7% | 1.01% | -19.9% |
Q1 2014 | $64,886,000 | +9.4% | 1,424,186 | -4.2% | 1.26% | +9.2% |
Q4 2013 | $59,291,000 | -11.1% | 1,486,373 | -2.3% | 1.16% | -16.1% |
Q3 2013 | $66,682,000 | +36.0% | 1,521,388 | -2.4% | 1.38% | +25.2% |
Q2 2013 | $49,037,000 | – | 1,558,696 | – | 1.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parametrica Management Ltd | 3,581 | $248,000 | 42.18% |
Baker Brothers Advisors | 50,057,277 | $3,464,464,000 | 23.54% |
Lagoda Investment Management, L.P. | 76,073 | $5,265,000 | 6.10% |
Matrix Capital Management Company, LP | 3,141,852 | $217,448,000 | 4.02% |
DOMINI IMPACT INVESTMENTS LLC | 3,111 | $215,000 | 2.98% |
Opus Point Partners Management, LLC | 17,901 | $1,239,000 | 1.83% |
EMORY UNIVERSITY | 33,593 | $2,325,000 | 1.64% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,215,000 | 1.56% |
Capital International Sarl | 130,400 | $9,025,000 | 1.26% |
CAPITAL GUARDIAN TRUST CO | 1,303,961 | $90,147,000 | 1.21% |